Jump to content

Biotechnology patent applications on 14th August 2025

From WikiPatents
Revision as of 06:24, 14 August 2025 by Wikipatents (talk | contribs) (Technology trend analysis for Biotechnology patent applications on 14th August 2025)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Biotechnology Patent Applications on 14th August 2025

Executive Summary

On 14th August 2025, 127 patent applications related to Biotechnology were published, representing 2.0% of all patent applications for the day. This moderate level of activity shows Biotechnology is gaining significant attention from innovators.

Market Analysis

Leading Organizations

The top organizations driving Biotechnology innovation include:

Template:Newsletter signup box

These 5 organizations account for 31 applications (24.4% of all Biotechnology patents), indicating a diverse and competitive landscape.

Technology Deep Dive

Core Innovation Areas

Patent applications in Biotechnology encompass several key innovation areas:

Technical Classification Analysis

The most active CPC classifications in Biotechnology include:

  • C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 23 applications (18.1%)
  • C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 18 applications (14.2%)
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 15 applications (11.8%)
  • C12Q1/6895 (involving nucleic acids): 14 applications (11.0%)
  • C12Q1/6869 (Methods for sequencing): 11 applications (8.7%)
  • C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 11 applications (8.7%)
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 11 applications (8.7%)
  • C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 11 applications (8.7%)
  • C12Q1/6883 (for diseases caused by alterations of genetic material): 10 applications (7.9%)
  • C12Q1/6874 (involving nucleic acid arrays, e.g. sequencing by hybridisation): 10 applications (7.9%)

Global Innovation Landscape

Innovation in Biotechnology spans multiple countries:

  • US: 289 inventors (67.2%)
  • CN: 34 inventors (7.9%)
  • KR: 26 inventors (6.0%)
  • DE: 14 inventors (3.3%)
  • SE: 12 inventors (2.8%)
  • JP: 8 inventors (1.9%)
  • CA: 8 inventors (1.9%)
  • GB: 7 inventors (1.6%)
  • FR: 7 inventors (1.6%)
  • IL: 6 inventors (1.4%)

The US accounts for 67.2% of inventors in Biotechnology, indicating strong domestic innovation leadership.

Industry Collaborations

Notable collaborations in Biotechnology include:

These collaborations represent 13 joint applications, indicating moderate industry cooperation in Biotechnology.

Leading Inventors

Key inventors driving Biotechnology innovation:

Recent Patent Applications

Representative Biotechnology patent applications from 14th August 2025:

20250255238. TRITICALE CULTIVAR APT1425621

Applicant: Legacy Seeds Acquisition Co 1 Llc

Abstract: A triticale variety, designated APT1425621, is disclosed. The invention relates to the seeds of triticale cultivar APT1425621, to the plants of triticale APT1425621, and to methods for producing a triticale plant produced by crossing the cultivar APT1425621 with itself or another triticale variety. The invention also relates to methods for producing a triticale plant containing in its genetic material one or more transgenes and to the transgenic triticale plants and plant parts produced by those...

20250255239. NOVEL MARKERS COMBINATION IN SWEET BASIL FOR DISEASE RESISTANCES

Applicant: Bar-Ilan University

Abstract: The present invention discloses a disease resistant cultivated basil plant and/or seed comprising a genomic sequence having an introgressed basil downy mildew (BDM) resistance or tolerance associated haplotype derived from

20250255240. SOYBEAN CULTIVAR 22080706

Applicant: Monsanto Technology LLC, Stine Seed Farm Inc

Abstract: A soybean cultivar designated 22080706 is disclosed. The invention relates to the seeds of soybean cultivar 22080706, to the plants of soybean cultivar 22080706, to the plant parts of soybean cultivar 22080706, and to methods for producing progeny of soybean cultivar 22080706. The invention also relates to methods for producing a soybean plant containing in its genetic material one or more transgenes and to the transgenic soybean plants and plant parts produced by those methods. The invention al...

20250255248. SOYBEAN CULTIVAR 26190173

Applicant: Monsanto Technology LLC, Stine Seed Farm Inc

Abstract: A soybean cultivar designated 26190173 is disclosed. The invention relates to the seeds of soybean cultivar 26190173, to the plants of soybean cultivar 26190173, to the plant parts of soybean cultivar 26190173, and to methods for producing progeny of soybean cultivar 26190173. The invention also relates to methods for producing a soybean plant containing in its genetic material one or more transgenes and to the transgenic soybean plants and plant parts produced by those methods. The invention al...

20250255249. SOYBEAN CULTIVAR 21120238

Applicant: Monsanto Technology LLC, Stine Seed Farm Inc

Abstract: A soybean cultivar designated 21120238 is disclosed. The invention relates to the seeds of soybean cultivar 21120238, to the plants of soybean cultivar 21120238, to the plant parts of soybean cultivar 21120238, and to methods for producing progeny of soybean cultivar 21120238. The invention also relates to methods for producing a soybean plant containing in its genetic material one or more transgenes and to the transgenic soybean plants and plant parts produced by those methods. The invention al...

Market Implications

Innovation Intensity

With 127 applications in a single day, Biotechnology demonstrates very high innovation intensity, suggesting rapid technological advancement and strong commercial interest.

Competitive Landscape

Innovation in Biotechnology involves 118 organizations, indicating a highly competitive and diverse landscape with many players investing in R&D.

Technology Outlook

Emerging themes in Biotechnology patents include: methods, soybean, relates, cultivar, nucleic, suggesting future development in these areas.

The current patent activity level suggests Biotechnology is in a growth phase with increasing market adoption and investment.

Related Technology Areas

Innovation in Biotechnology often intersects with other emerging technologies:

Analysis Tools

Search Resources

See Also

Cookies help us deliver our services. By using our services, you agree to our use of cookies.